RxSight, Inc. RXST
Set alert
At close · Oct 30
After hours · Oct 30, 5:41 PM ET
- YTD
- -53.26%
- 1 year
- -43.31%
- Open
- 5.06
- Prev close
- 5.05
- Mkt cap
- 202.56M
- Vol
- 468.49K
- Avg vol
- 785.00K
- EPS
- -1.14
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.85
- High
- 5.07
- Forward P/E
- -49.73
- Beta
- 1.22
- Short ratio
- 4.55
- Inst. own
- 91.19%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 7, 2024
- 50-d avg
- 29.42
- 200-d avg
- 43.84
- 1y target
- 41.90
5D chart
Signals (85)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 3:55 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 3:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:50 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 3:40 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 2 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 2 days ago |
| SMA: Bullish | Oct 30, 2:20 PM | 2 days ago |
| RSI: Oversold | Oct 30, 2:10 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:25 PM | 2 days ago |
| RSI: Oversold | Oct 30, 12:45 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:40 PM | 2 days ago |
| SMA: Bearish | Oct 30, 12:35 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:25 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:00 PM | 2 days ago |
| SMA: Bearish | Oct 30, 11:25 AM | 2 days ago |
| MACD: Buy Signal | Oct 30, 10:40 AM | 2 days ago |
| RSI: Oversold | Oct 30, 10:15 AM | 2 days ago |
| MACD: Sell Signal | Oct 30, 9:35 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bearish | Oct 30, 9:30 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:35 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:20 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:10 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:50 PM | 3 days ago |
| SMA: Bullish | Oct 29, 2:05 PM | 3 days ago |
| SMA: Bearish | Oct 29, 1:05 PM | 3 days ago |
| SMA: Bearish | Oct 29, 12:15 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 12:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 12:00 PM | 3 days ago |
| SMA: Bullish | Oct 29, 11:55 AM | 3 days ago |
| RSI: Overbought | Oct 29, 11:55 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:50 AM | 3 days ago |
| SMA: Bearish | Oct 29, 11:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 10:50 AM | 3 days ago |
| RSI: Overbought | Oct 29, 10:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 10:40 AM | 3 days ago |
| RSI: Overbought | Oct 29, 10:40 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 10:15 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:45 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:30 AM | 3 days ago |
| RSI: Overbought | Oct 28, 3:40 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 2:10 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 2:10 PM | 4 days ago |
| RSI: Oversold | Oct 28, 12:25 PM | 4 days ago |
| SMA: Bearish | Oct 28, 12:05 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:40 AM | 4 days ago |
| SMA: Bullish | Oct 28, 11:35 AM | 4 days ago |
| RSI: Oversold | Oct 28, 11:00 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:50 AM | 4 days ago |
| SMA: Bearish | Oct 27, 3:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 3:05 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 2:55 PM | 5 days ago |
| RSI: Overbought | Oct 27, 1:45 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:30 PM | 5 days ago |
| SMA: Bullish | Oct 27, 1:30 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 1:30 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 1:20 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:40 PM | 5 days ago |
| SMA: Bearish | Oct 27, 12:40 PM | 5 days ago |
| SMA: Bullish | Oct 27, 12:15 PM | 5 days ago |
| MACD: Buy Signal | Oct 27, 12:15 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:40 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:15 AM | 5 days ago |
| SMA: Bearish | Oct 27, 11:15 AM | 5 days ago |
| SMA: Bullish | Oct 27, 11:05 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:55 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 10:30 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 10:15 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:00 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:45 AM | 5 days ago |
| RSI: Oversold | Oct 26, 3:25 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:10 PM | 6 days ago |
| SMA: Bearish | Oct 26, 3:10 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 3:10 PM | 6 days ago |
| RSI: Oversold | Oct 26, 3:10 PM | 6 days ago |
| SMA: Bullish | Oct 26, 3:00 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:15 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 12:45 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bearish | Oct 26, 12:30 PM | 6 days ago |
| SMA: Bullish | Oct 26, 12:25 PM | 6 days ago |
| SMA: Bearish | Oct 26, 10:35 AM | 6 days ago |
News
1 week ago globenewswire.com
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
ALISO VIEJO, Calif., Oct. 23, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on October 23, 2026, RxSight granted inducement stock options to purchase a total of 236,456…
1 week ago globenewswire.com
RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3
ALISO VIEJO, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the third quarter of 2026 after the market close on…
1 week ago globenewswire.com
RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation
ALISO VIEJO, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced the appointments of Taryn Conway as Chief Commercial Officer and Frank Shields as Executive Vice…
2 weeks ago globenewswire.com
K2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the world
K2 Vision has performed 5,000+ Light Adjustable Lens procedures and is recognized by RxSight as the highest-volume LAL practice in the world. Learn more.
3 weeks ago defenseworld.net
Reviewing Bioventus (NASDAQ:BVS) & RxSight (NASDAQ:RXST)
RxSight (NASDAQ: RXST - Get Free Report) and Bioventus (NASDAQ: BVS - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies…
3 weeks ago defenseworld.net
RxSight (NASDAQ:RXST) and Organigram Global (NASDAQ:OGI) Financial Survey
RxSight (NASDAQ: RXST - Get Free Report) and Organigram Global (NASDAQ: OGI - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two…
1 month ago defenseworld.net
RxSight (NASDAQ:RXST) & Cerus (NASDAQ:CERS) Critical Analysis
Cerus (NASDAQ: CERS - Get Free Report) and RxSight (NASDAQ: RXST - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based…
-
1 month ago benzinga.com
B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $5.5
B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $6.5 to $5.5.
1 month ago defenseworld.net
85,838 Shares in RxSight, Inc. $RXST Purchased by Corient Private Wealth LP
Corient Private Wealth LP bought a new stake in shares of RxSight, Inc. (NASDAQ: RXST) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor…
1 month ago defenseworld.net
BlackRock Inc. Purchases Shares of 5,790,408 RxSight, Inc. $RXST
BlackRock Inc. acquired a new stake in RxSight, Inc. (NASDAQ: RXST) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The…
2 months ago globenewswire.com
RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference
ALISO VIEJO, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that management is scheduled to participate in the Wells Fargo Healthcare Conference on Wednesday,…
-
2 months ago benzinga.com
Stifel Maintains Hold on RxSight, Lowers Price Target to $7
Stifel analyst Tom Stephan maintains RxSight (NASDAQ:RXST) with a Hold and lowers the price target from $8 to $7.
2 months ago defenseworld.net
Head-To-Head Comparison: RxSight (NASDAQ:RXST) and Futureworld (OTCMKTS:FWDG)
RxSight (NASDAQ: RXST - Get Free Report) and Futureworld (OTCMKTS:FWDG - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two businesses…
-
2 months ago benzinga.com
UBS Maintains Neutral on RxSight, Raises Price Target to $6.3
UBS analyst Patrick Wood maintains RxSight (NASDAQ:RXST) with a Neutral and raises the price target from $5.5 to $6.3.
2 months ago seekingalpha.com
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
RxSight, Inc. (RXST) Q2 2026 Earnings Call Transcript
2 months ago marketbeat.com
RxSight Q2 Earnings Call Highlights
RxSight NASDAQ: RXST reported second-quarter revenue of $33.7 million, including $6.5 million recognized under its strategic collaboration with Alcon, while management withdrew its full-year 2026…
-
2 months ago defenseworld.net
RxSight Q2 Earnings Call Highlights
RxSight (NASDAQ: RXST) reported second-quarter revenue of $33.7 million, including $6.5 million recognized under its strategic collaboration with Alcon, while management withdrew its full-year 2026…
2 months ago zacks.com
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates
RxSight, Inc. (RXST) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to a loss of $0.08 per share a year ago.
2 months ago globenewswire.com
RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook
ALISO VIEJO, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today reported financial results for the quarter ended June 30, 2026, and provided an update on its 2026 financial…
3 months ago zacks.com
Earnings Preview: RxSight, Inc. (RXST) Q2 Earnings Expected to Decline
RxSight (RXST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 months ago globenewswire.com
RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
ALISO VIEJO, Calif. , July 26, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST) today announced that on July 24, 2026, RxSight granted inducement stock options to purchase a total of 571,286…
3 months ago zacks.com
RxSight (RXST) Surges 6.1%: Is This an Indication of Further Gains?
RxSight (RXST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the…
-
3 months ago benzinga.com
RxSight Appoints Aziz Mottiwala President, CEO, Effective July 20, Succeeding Ron Kurtz
RxSight, Inc. (NASDAQ:RXST) today announced a planned leadership transition effective July 20, 2026, with Aziz Mottiwala appointed President and Chief Executive Officer, succeeding Ron Kurtz, M.D.,…
-
3 months ago benzinga.com
B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $6.5
B of A Securities analyst Craig Bijou maintains RxSight (NASDAQ:RXST) with a Underperform and lowers the price target from $8 to $6.5.
3 months ago benzinga.com
Stock Market Today: Dow Jones Futures Gain, S&P 500, Nasdaq 100 Slips As SpaceX Debuts On The Exchange—Rivian, Micron In Focus (UPDATED)
U.S. stock futures were mixed on Tuesday, as the Dow Jones index rose while the Nasdaq 100 and S&P 500 indices fell.
3 months ago benzinga.com
Rivian Automotive, Penguin Solutions And 3 Stocks To Watch Heading Into Tuesday
US stock futures trade lower, investors focus on PENG, RXST, SAR earnings, RIVN's public offering, and EPAC's expected earnings. Check premarket coverage.
3 months ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-market session. Crinetics Pharmaceuticals (NASDAQ:CRNX) stock moved upwards by 99.85% to $84.0. The…
-
3 months ago benzinga.com
Alcon And RxSight Announce A Non-Exclusive Collaboration To Jointly Develop Adjustable Presbyopia-Correcting Intraocular Lenses
Alcon (NYSE:ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ:RXST), an ophthalmic medical device company dedicated to providing high-quality…
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
8 months ago benzinga.com
Earnings Scheduled For February 25, 2026
Earnings Scheduled For February 25, 2026
9 months ago benzinga.com
Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday
Planet Labs PBC, Day One Biopharmaceuticals, Rxsight, SunOpta And Other Big Stocks Moving Higher On Monday
11 months ago benzinga.com
Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday
Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday
-
12 months ago benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Pre-Market Session
12 months ago benzinga.com
Earnings Scheduled For November 5, 2025
Earnings Scheduled For November 5, 2025
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
1 year ago benzinga.com
Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May
Dow Jumps 200 Points; US Wholesale Inventories Fall 0.3% In May
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
1 year ago benzinga.com
Why AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
12 Health Care Stocks Moving In Tuesday's After-Market Session
1 year ago benzinga.com
RH Posts Downbeat Earnings, Joins Apple, Tesla, Nvidia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
RH Posts Downbeat Earnings, Joins Apple, Tesla, Nvidia And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
1 year ago benzinga.com
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
-
1 year ago benzinga.com
Earnings Scheduled For February 25, 2025
Earnings Scheduled For February 25, 2025
-
2 years ago benzinga.com
Earnings Scheduled For February 28, 2024
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.
-
2 years ago benzinga.com
Earnings Scheduled For November 9, 2023
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million.
-
3 years ago benzinga.com
Earnings Scheduled For August 7, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report quarterly loss at $0.44 per share on revenue of $153.69 million.
-
3 years ago benzinga.com
Earnings Scheduled For May 9, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
-
3 years ago benzinga.com
Earnings Scheduled For March 6, 2023
Companies Reporting Before The Bell • Passage Bio (NASDAQ:PASG) is estimated to report earnings for its fourth quarter.